Jennifer A. Sorensen
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Patients With Chronic Urticaria Have Higher Health-Care Resource Utilisation: A Danish Nationwide Case-Control Study.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: November 15, 2025
Performance of omalizumab in patients with mast cell-mediated angioedema with and without wheals.
Journal: The journal of allergy and clinical immunology. In practice
Published: November 06, 2025
Early response patterns on omalizumab predict long-term outcomes in chronic spontaneous urticaria.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: October 02, 2025
Rational design of antibodies with pH-dependent antigen-binding properties using structural insights from broadly neutralizing antibodies against α-neurotoxins.
Journal: mAbs
Published: September 12, 2025
Temporal Trends in the Course and Management of Chronic Urticaria at a European Tertiary Center.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: July 21, 2025
Exploring the impact of chronic urticaria profile as a key predictor of alexithymia: A cross-sectional study.
Journal: Clinical and translational allergy
Published: January 27, 2025
Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long-Term Multicentre Real-World Study.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: January 24, 2025
EXtending Omalizumab Treatment Intervals in patients with Chronic spontaneous urticaria (EXOTIC): protocol of a multicentre, randomised, open-label, non-inferiority trial.
Journal: BMJ open
Published: January 06, 2025
Omalizumab dosing patterns and drug survival in adult patients with chronic spontaneous urticaria.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: December 20, 2024
Oral Roflumilast Suppresses Proinflammatory Cytokine Signaling and Reduces CD4+ T-Cell and Neutrophil Infiltration in Psoriasis.
Journal: The Journal of investigative dermatology
Published: December 16, 2024
Paradoxical psoriasis after dupilumab treatment of prurigo nodularis treated with adalimumab.
Journal: JAAD case reports
Published: October 14, 2024
Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation.
Journal: JAMA dermatology
Published: July 17, 2024
Last Updated: 09/26/2026